|
SON expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.09249999999895E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.005160E-04 |
| Normal-vs-Stage2 |
4.123600E-02 |
| Normal-vs-Stage3 |
6.335100E-03 |
| Normal-vs-Stage4 |
2.396300E-02 |
| Stage1-vs-Stage2 |
9.586800E-01 |
| Stage1-vs-Stage3 |
7.354000E-01 |
| Stage1-vs-Stage4 |
5.382400E-01 |
| Stage2-vs-Stage3 |
7.612200E-01 |
| Stage2-vs-Stage4 |
5.409400E-01 |
| Stage3-vs-Stage4 |
6.986400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77064999999921E-05 |
| Normal-vs-AfricanAmerican |
3.574200E-02 |
| Normal-vs-Asian |
8.435200E-03 |
| Caucasian-vs-AfricanAmerican |
2.383400E-01 |
| Caucasian-vs-Asian |
7.837600E-01 |
| AfricanAmerican-vs-Asian |
4.999600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.04649999999695E-05 |
| Normal-vs-Female |
4.274200E-02 |
| Male-vs-Female |
1.420560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.016600E-04 |
| Normal-vs-Extreme_Weight |
4.47260000000504E-05 |
| Normal-vs-Obese |
8.200300E-02 |
| Normal-vs-Extreme_Obese |
7.058100E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.867400E-01 |
| Normal_Weight-vs-Obese |
1.437350E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.546600E-01 |
| Extreme_Weight-vs-Obese |
7.681600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.632200E-01 |
| Obese-vs-Extreme_Obese |
1.516240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.626000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.555990E-02 |
| Normal-vs-Age(61-80Yrs) |
4.30380000004948E-06 |
| Normal-vs-Age(81-100Yrs) |
4.204100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.333800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.936240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.488100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.683900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.738400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.562200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.659000E-03 |
| Normal-VS-Type2 PRCC |
1.38730000043275E-07 |
| Normal-VS-KIRP CIMP |
2.194200E-01 |
| Normal-VS-Unclassified PRCC |
1.672190E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.801600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.211600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.403800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.369200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.218800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.621600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.07719999978373E-07 |
| Normal-vs-N1 |
3.737600E-01 |
| Normal-vs-N2 |
6.079200E-03 |
| N0-vs-N1 |
6.627800E-02 |
| N0-vs-N2 |
8.832400E-01 |
| N1-vs-N2 |
3.765600E-01 |
|
|
